An upcoming public $100 million offer from Nano-X Imaging is so close as Yahoo Finance has started tracking. As a healthcare company that scans and delivers the human body condition with the latest X-Ray technology.
Just like CureVac, NNOX could possibly blast off due to the rising age of healthcare firms during the pandemic. Pouring the funds into R&D has led Nano-X Imaging to the loss in recent years. Therefore public fundraising might push it to the next level of earning the revenue and possible net income could be guaranteed.
Adding NNOX to the watchlist and setting alarm to the time when the stock rides over the IPO price is the smartest strategy in weighing investment alternatives.
Finance and Tech Contributor